Toll Free : 1-800-489-3075

Global Coronary Artery Disease Therapeutics Market 2017-2021

Choose License Type
Published by:




Published On:

October 2017

No of pages:


Report Format:

Electronic (PDF)

About Coronary Artery Disease Therapeutics

Coronary artery disease (CAD) is the most common type of heart disease and is one of the leading causes of death globally. It can lead to complications including myocardial infarction, stable angina, unstable angina, and sudden cardiac death. CAD is the narrowing of the coronary arteries that prevents the supply of an adequate amount of blood supply to the heart. It happens when a coronary artery gets hardened or narrowed due to various reasons such as the build-up of cholesterol or other materials known as plaque on the inner wall of the artery. This build-up is known as atherosclerosis. With passing time, a lesser amount of blood flows through the arteries. As a result heart muscle fails to get the required amount of blood or oxygen.

Technavio's analysts forecast the global coronary artery disease therapeutics market to grow at a CAGR of 5.17% during the period 2017-2021.

Covered in this report 

The report covers the present scenario and the growth prospects of the global coronary artery disease therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Coronary Artery Disease Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • AstraZeneca • Gilead • Novartis • Pfizer
Other prominent vendors • Bayer, • Bristol-Myers Squibb, • GlaxoSmithKline, • Merck, • Mylan, • Teva Pharmaceutical Industries
Market driver • Growing geriatric population • For a full, detailed list, view our report Market challenge • Highly genericized market • For a full, detailed list, view our report Market trend • Growing strategic alliances • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.